ALBANY, N.Y., Nov. 12, 2019 /PRNewswire/ -- Today the New York Health Collaborative (NYeC) announced that use of the Statewide Health Information Network for New York (SHIN-NY) is reducing unnecessary healthcare spending in New York State by $160-$1

PENNINGTON, N.J., Nov. 12, 2019 /PRNewswire/ -- Dr. Joyce Varughese, a board certified, fellowship trained gynecologic oncologist, has joined Capital Health Surgical Group and is now part of the nationally accredited Capital Health Cancer Center, located at Capital Health Medical Center – Hopewell

SAN FRANCISCO and SEATTLE, Nov. 12, 2019 /PRNewswire/ -- With a $106 million gift from the Weill Family Foundation, UC Berkeley (Berkeley), UC San Francisco (UCSF), and the University of Washington (the UW) have l

BOSTON, Nov. 12, 2019 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts (Blue Cross) has added an innovative online reso

MISSOULA, Mont., Nov. 12, 2019 /PRNewswire/ -- Expesicor, a privately held, Montana-based company focused on preventing, treating, and curing neurological disor

LEXINGTON, Mass., Nov. 12, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1 and cancer vaccines, announced that it will host an R&D Day on November 15, 2019. Date: Friday, November 15, 20

W. CONSHOHOCKEN, Pa., Nov. 12, 2019 /PRNewswire/ -- Last week, Mexico City signed a memorandum of cooperation (MOC) with global standards developer ASTM International. The agreement is specifically focused on internationally-recognized standards maintained by the organization's committee on amusement rides and devices.

COPENHAGEN, Denmark, Nov. 12, 2019 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today published its Interim Report for the first nine months of 2019.  This Company Release should be read in conjunction with Veloxis's full Interim Report for the first nine months of 2019, which is attached to this release and also available on Veloxis's website at:

HERTFORDSHIRE, England, PITTSBURGH and NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pronounced 'viǝ-tr

BOULDER Colo., Nov. 12, 2019 /PRNewswire/ -- nVoq, a leading provider of HIPAA compliant speech recognition solutions for the healthcare industry, is pleased to announce its partnership with Amedisys, Inc. (NASDAQ: AMED), America's leading independent home health, hospice and personal care company.  The partnership will leverage nVoq's innovative technology pla